Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 May 10;30(14):1663-9.
doi: 10.1200/JCO.2011.37.8018. Epub 2012 Mar 12.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

Stephen P Hunger  1 , Xiaomin Lu, Meenakshi Devidas, Bruce M Camitta, Paul S Gaynon, Naomi J Winick, Gregory H Reaman, William L Carroll
Affiliations
Comparative Study

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

Stephen P Hunger et al. J Clin Oncol. .

Abstract

Purpose: To examine population-based improvements in survival and the impact of clinical covariates on outcome among children and adolescents with acute lymphoblastic leukemia (ALL) enrolled onto Children's Oncology Group (COG) clinical trials between 1990 and 2005.

Patients and methods: In total, 21,626 persons age 0 to 22 years were enrolled onto COG ALL clinical trials from 1990 to 2005, representing 55.8% of ALL cases estimated to occur among US persons younger than age 20 years during this period. This period was divided into three eras (1990-1994, 1995-1999, and 2000-2005) that included similar patient numbers to examine changes in 5- and 10-year survival over time and the relationship of those changes in survival to clinical covariates, with additional analyses of cause of death.

Results: Five-year survival rates increased from 83.7% in 1990-1994 to 90.4% in 2000-2005 (P < .001). Survival improved significantly in all subgroups (except for infants age ≤ 1 year), including males and females; those age 1 to 9 years, 10+ years, or 15+ years; in whites, blacks, and other races; in Hispanics, non-Hispanics, and patients of unknown ethnicity; in those with B-cell or T-cell immunophenotype; and in those with National Cancer Institute (NCI) standard- or high-risk clinical features. Survival rates for infants changed little, but death following relapse/disease progression decreased and death related to toxicity increased.

Conclusion: This study documents ongoing survival improvements for children and adolescents with ALL. Thirty-six percent of deaths occurred among children with NCI standard-risk features emphasizing that efforts to further improve survival must be directed at both high-risk subsets and at those children predicted to have an excellent chance for cure.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
Overall survival probability by treatment era for patients enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A1.
Fig A1.
Overall survival probability for patients with acute lymphoblastic leukemia of different ages enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005; (A) infants age ≤ 1 year, and persons age (B) 1 to 9.99 years, (C) 10 years or older, and (D) 15 years or older.
Fig A2.
Fig A2.
Overall survival probability for (A) males and (B) females enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A3.
Fig A3.
Overall survival probability for (A) whites, (B) blacks, and (C) persons of other ethnicities enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A4.
Fig A4.
Overall survival probability for persons who reported themselves as (A) Hispanic, (B) non-Hispanic, or (C) unknown ethnicity enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A5.
Fig A5.
Overall survival probability by leukemia immunophenotype for patients with (A) B-cell and (B) T-cell acute lymphoblastic leukemia enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A6.
Fig A6.
Overall survival probability by National Cancer Institute risk group for patients with (A) standard-risk (age 1-9.99 years and initial WBC count < 50,000/μL) and (B) high-risk (age 10 years or older and/or initial WBC count > 50,000/μL) acute lymphoblastic leukemia enrolled onto Children's Oncology Group trials in 1990-1994, 1995-1999, and 2000-2005.
Fig A7.
Fig A7.
Survival tree regression analysis was performed by using complete data for (A) patients older than age 1 year (yr); and (B) infants age ≤ 1 year. NCI, National Cancer Institute; OS, overall survival.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ries LAG, Smith MA, Gurney JG, et al., editors. NIH Pub. No. 99-4649. Bethesda, MD: 1999. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995.
    1. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741. - PMC - PubMed
    1. Veerman AJ, Kamps WA, van den Berg H, et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: Results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004) Lancet Oncol. 2009;10:957–966. - PubMed
    1. Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: A report from the Children's Oncology Group. Leukemia. 2010;24:355–370. - PMC - PubMed
    1. Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the Children's Cancer Group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report. Leukemia. 2010;24:285–297. - PMC - PubMed

Publication types

MeSH terms